Skip to main content

Krogulski Kenneth's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Dec 3, 2021

Accession no.
0001209191-21-067883
Filed
Dec 3, 2021
Trade date
Nov 1-30, 2021
Filing delay
32 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $5.60K. It was filed 32 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krogulski KennethCIK 0001695580Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 1, 2021Common StockPPurchaseAcquired+85$2.67+$226.95179,225Direct
Nov 2, 2021Common StockPPurchaseAcquired+85$2.63+$223.55179,310Direct
Nov 3, 2021Common StockPPurchaseAcquired+85$2.71+$230.35179,395Direct
Nov 4, 2021Common StockPPurchaseAcquired+85$2.76+$234.6179,480Direct
Nov 5, 2021Common StockPPurchaseAcquired+85$2.71+$230.35179,565Direct
Nov 8, 2021Common StockPPurchaseAcquired+85$2.95+$250.75179,650Direct
Nov 9, 2021Common StockPPurchaseAcquired+85$3.21+$272.85179,735Direct
Nov 10, 2021Common StockPPurchaseAcquired+85$2.94+$249.9179,820Direct
Nov 11, 2021Common StockPPurchaseAcquired+85$2.83+$240.55179,905Direct
Nov 12, 2021Common StockPPurchaseAcquired+85$2.67+$226.95179,990Direct
Nov 15, 2021Common StockPPurchaseAcquired+85$2.71+$230.35180,075Direct
Nov 16, 2021Common StockPPurchaseAcquired+85$2.66+$226.1180,160Direct
Nov 17, 2021Common StockPPurchaseAcquired+85$2.58+$219.3180,245Direct
Nov 18, 2021Common StockPPurchaseAcquired+85$2.58+$219.3180,330Direct
Nov 19, 2021Common StockPPurchaseAcquired+85$2.55+$216.75180,415Direct
Nov 22, 2021Common StockPPurchaseAcquired+85$2.35+$199.75180,500Direct
Nov 23, 2021Common StockPPurchaseAcquired+85$2.29+$194.65180,585Direct
Nov 24, 2021Common StockPPurchaseAcquired+150$2.31+$346.5180,735Direct
Nov 26, 2021Common StockPPurchaseAcquired+150$2.26+$339180,885Direct
Nov 29, 2021Common StockPPurchaseAcquired+150$2.23+$334.5181,035Direct
Nov 30, 2021Common StockPPurchaseAcquired+150$4.61+$691.5181,185Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)